RS61222B1 - Ciklopiroks, ciklopiroksolamin, ili prolek ciklopiroksa za upotrebu u lečenju kancera bešike - Google Patents

Ciklopiroks, ciklopiroksolamin, ili prolek ciklopiroksa za upotrebu u lečenju kancera bešike

Info

Publication number
RS61222B1
RS61222B1 RS20201438A RSP20201438A RS61222B1 RS 61222 B1 RS61222 B1 RS 61222B1 RS 20201438 A RS20201438 A RS 20201438A RS P20201438 A RSP20201438 A RS P20201438A RS 61222 B1 RS61222 B1 RS 61222B1
Authority
RS
Serbia
Prior art keywords
ciclopirox
treatment
prodrug
bladder cancer
olamine
Prior art date
Application number
RS20201438A
Other languages
English (en)
Inventor
Scott J Weir
Shrikant Anant
Original Assignee
Univ Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas filed Critical Univ Kansas
Publication of RS61222B1 publication Critical patent/RS61222B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RS20201438A 2014-11-11 2015-11-10 Ciklopiroks, ciklopiroksolamin, ili prolek ciklopiroksa za upotrebu u lečenju kancera bešike RS61222B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462078069P 2014-11-11 2014-11-11
US201562134747P 2015-03-18 2015-03-18
PCT/US2015/059955 WO2016077346A1 (en) 2014-11-11 2015-11-10 Methods of bladder cancer treatment with ciclopirox, ciclopirox olamine, or a ciclopirox prodrug
EP15859268.3A EP3217980B1 (en) 2014-11-11 2015-11-10 Ciclopirox, ciclopirox olamine, or a ciclopirox prodrug for use in the treatment of bladder cancer

Publications (1)

Publication Number Publication Date
RS61222B1 true RS61222B1 (sr) 2021-01-29

Family

ID=55954945

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20201438A RS61222B1 (sr) 2014-11-11 2015-11-10 Ciklopiroks, ciklopiroksolamin, ili prolek ciklopiroksa za upotrebu u lečenju kancera bešike

Country Status (11)

Country Link
US (1) US20170304329A1 (sr)
EP (1) EP3217980B1 (sr)
JP (1) JP2017533952A (sr)
CN (2) CN116687941A (sr)
DK (1) DK3217980T3 (sr)
ES (1) ES2836208T3 (sr)
HR (1) HRP20201893T1 (sr)
HU (1) HUE052670T2 (sr)
PT (1) PT3217980T (sr)
RS (1) RS61222B1 (sr)
WO (1) WO2016077346A1 (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112351970A (zh) * 2018-05-30 2021-02-09 科莱恩国际有限公司 2-羟基吡啶-1-氧化物或其衍生物的形成方法
WO2020040327A1 (ko) * 2018-08-23 2020-02-27 광주과학기술원 시클로피록스의 hbv 코어조립 저해 용도
WO2021078937A1 (en) * 2019-10-25 2021-04-29 Deutsches Krebsforschungszentrum Treatment of stat3 related diseases by iron chelators
EP4193989A1 (en) 2021-12-09 2023-06-14 Atlas Molecular Pharma, S.L. A formulation for an effective oral administration of ciclopirox with no adversal gasterointestinal toxicity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051181B1 (en) 1997-12-31 2004-03-17 The University Of Kansas Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
AU2003251875A1 (en) * 2002-07-15 2004-02-02 Combinatorx, Incorporated Combination therapy for the treatment of neoplasms
WO2010048712A1 (en) 2008-10-31 2010-05-06 University Health Network Ciclopirox and cytarabine for the treatment of leukemic disorders
HUE028411T2 (en) 2010-12-02 2016-12-28 Univ Kansas Precursors and derivatives of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2 (1H) -one \ t

Also Published As

Publication number Publication date
HRP20201893T1 (hr) 2021-02-05
PT3217980T (pt) 2020-12-11
WO2016077346A1 (en) 2016-05-19
ES2836208T3 (es) 2021-06-24
EP3217980A4 (en) 2018-05-02
CN107206012A (zh) 2017-09-26
EP3217980B1 (en) 2020-10-14
CN116687941A (zh) 2023-09-05
US20170304329A1 (en) 2017-10-26
JP2017533952A (ja) 2017-11-16
HUE052670T2 (hu) 2021-05-28
EP3217980A1 (en) 2017-09-20
DK3217980T3 (da) 2020-12-07

Similar Documents

Publication Publication Date Title
HK1256283A1 (zh) 治療癌症有用的二氫咪唑並吡嗪酮衍生物
IL249370A0 (en) Fap-enabled medical substances and related uses
IL251630A0 (en) Combined therapy for use in cancer treatment
RS61536B1 (sr) Kombinacije fgfr- i cmet-inhibitora za lečenje kancera
IL251905A0 (en) Epilimod for use in the treatment of kidney cancer
IL248767B (en) Trimethoxyphenyl-benzaimidazole compounds for cancer treatment
IL276733A (en) Use of Aribolin in cancer treatment
IL251903B (en) Epilimod for use in the treatment of colon cancer
RS61222B1 (sr) Ciklopiroks, ciklopiroksolamin, ili prolek ciklopiroksa za upotrebu u lečenju kancera bešike
EP3440052C0 (en) COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
HK1251476A1 (zh) 用於治療癌症的氨基硫羥酸酯化合物或其藥學上可接受的鹽
GB201417819D0 (en) Agents for cancer therapy